Experts discuss the importance of transitioning cancer care from academic centers to community practices, ensuring patient ...

Recent regulatory actions from the FDA, including new drug application (NDA) acceptances and labeling updates, introduce new clinical considerations for oncology nurses and advanced practice providers ...

The NDA is supported by data from the EXCALIBER-RRMM trial, which evaluated the safety and efficacy of iberdomide, an investigational cereblon E3 ligase modulator.

The Oncology Nurse Advisor Summit spotlights CAR T-cell therapy, bispecific antibodies, and immunotherapy nursing best practices.

Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...

If you or a loved one has multiple myeloma, you may want to think about palliative care. Although it’s often mistaken for “end-of-life” care, palliative care simply means treating the symptoms, pain, ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

Bortezomib, Doxorubicin and Dexamethasone in Advanced Multiple Myeloma Advanced multiple myeloma treatment -- discover the results of a first time combination of bortezomib, doxorubicin and low-dose ...

About the Role The Multiple Myeloma Nurse Coordinator will facilitate evidence based individualized, coordinated care for patients with haematological malignancies across the cancer trajectory. The ...

Multiple myeloma is the second most commonly diagnosed type of blood cancer (after lymphoma). But it’s still relatively uncommon. Around the world, there were about 180,000 new cases in 2022. That ...